Emergency Preparedness and Response
State and Local Stakeholders
FDA works closely with State and Local stakeholders to make available safe and effective medical countermeasures during public health emergencies. FDA also establishes policies to safeguard medical products from adulteration and prevent supplies from being disrupted during a naturally occurring public emergency or deliberate threat.
October 12, 2012, FDA Legal Preparedness Tools for Distributing and Dispensing Medical Countermeasures, 2012 Public Health Law Conference: Practical Approaches to Critical Challenges, American Society of Law, Medicine & Ethics and the Network for Public Health Law, Atlanta, GA.
- March 15, 2012, Recent Developments in FDA's Emergency Authority for Medical Countermeasures, from the Public Health Law Webinar Series
- February 2012, National Association of County & City Health Officials (NACCHO) Public Health Preparedness Summit 2012: Regroup, Refocus, Refresh: Sustaining Preparedness in an Economic Crisis
– Improving a Path Forward: New Steps in Anthrax Planning, FDA Anthrax Preparedness / FDA Response Planning and Execution CAPT Carmen Maher, Acting Deputy Director,
FDA's Office of Counterterrorism and Emerging Threats, and LCDR Anthony (Tony) Garza, FDA Office of Countertorrorism and Emerging Threats
– Intro to Medical Countermeasures Policy, Products, and Practice, FDA's Role in Medical Countermeasures--Current Issues and Challenges, Brooke Courtney, JD, MPH,
Regulatory Counsel, FDA Office of Countertorrorism and Emerging Threats
– FDA, Recent Medical Countermeasures Issues & Developments Everything You Wanted to Know and Ask about Medical Countermeasures